CARDIFF ONCOLOGY, INC. Stock Issued
CARDIFF ONCOLOGY, INC. (CRDF) reported Stock Issued of $1.74 million for the 161-month period ending 2012-12-31, per its 10-K filed 2013-04-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2013-04-01
- 2012-12-31: Stock Issued 161 month $1.74M.
- 2012-09-30: Stock Issued 158 month $1.74M.
- 2012-06-30: Stock Issued 155 month $1.74M.
- 2012-03-31: Stock Issued 152 month $1.74M.
| Period end | Stock Issued 152 month | Stock Issued 155 month | Stock Issued 158 month | Stock Issued 161 month |
|---|---|---|---|---|
| 2012-12-31 | $1.74M 10-K · filed 2013-04-01 | |||
| 2012-09-30 | $1.74M 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | $1.74M 10-Q · filed 2012-08-14 | |||
| 2012-03-31 | $1.74M 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |